A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 86,208 shares of TMO stock, worth $45.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
86,208
Previous 92,057 6.35%
Holding current value
$45.6 Million
Previous $50.9 Million 4.74%
% of portfolio
0.07%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$531.86 - $624.21 $3.11 Million - $3.65 Million
-5,849 Reduced 6.35%
86,208 $53.3 Million
Q2 2024

Jul 19, 2024

BUY
$541.52 - $599.02 $1.4 Million - $1.55 Million
2,591 Added 2.9%
92,057 $50.9 Million
Q1 2024

Apr 22, 2024

BUY
$528.82 - $599.43 $1.86 Million - $2.11 Million
3,518 Added 4.09%
89,466 $52 Million
Q4 2023

Jan 16, 2024

BUY
$431.41 - $532.94 $1.41 Million - $1.74 Million
3,258 Added 3.94%
85,948 $45.6 Million
Q3 2023

Oct 24, 2023

BUY
$498.29 - $574.41 $496,795 - $572,686
997 Added 1.22%
82,690 $41.9 Million
Q2 2023

Jul 25, 2023

BUY
$508.46 - $591.13 $155,588 - $180,885
306 Added 0.38%
81,693 $42.6 Million
Q1 2023

Apr 14, 2023

SELL
$535.0 - $604.82 $1.09 Million - $1.23 Million
-2,033 Reduced 2.44%
81,387 $46.9 Million
Q4 2022

Feb 08, 2023

SELL
$484.71 - $571.37 $4.18 Million - $4.93 Million
-8,624 Reduced 9.37%
83,420 $45.9 Million
Q3 2022

Oct 25, 2022

BUY
$507.19 - $604.49 $73,035 - $87,046
144 Added 0.16%
92,044 $46.7 Million
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $3.56 Million - $4.35 Million
-7,108 Reduced 7.18%
91,900 $50 Million
Q1 2022

May 11, 2022

SELL
$524.0 - $644.92 $3.13 Million - $3.86 Million
-5,982 Reduced 5.7%
99,008 $58.5 Million
Q4 2021

Feb 08, 2022

BUY
$569.0 - $667.24 $131,439 - $154,132
231 Added 0.22%
104,990 $70.1 Million
Q3 2021

Nov 02, 2021

SELL
$509.53 - $609.78 $2.63 Million - $3.14 Million
-5,152 Reduced 4.69%
104,759 $59.9 Million
Q2 2021

Aug 11, 2021

BUY
$441.0 - $508.24 $3.06 Million - $3.53 Million
6,944 Added 6.74%
109,911 $55.5 Million
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $5.46 Million - $6.44 Million
12,411 Added 13.71%
102,967 $47 Million
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $1.19 Million - $1.44 Million
2,737 Added 3.12%
90,556 $42.2 Million
Q3 2020

Nov 04, 2020

SELL
$359.77 - $441.52 $97,857 - $120,093
-272 Reduced 0.31%
87,819 $38.8 Million
Q2 2020

Jul 17, 2020

BUY
$275.2 - $362.34 $24.2 Million - $31.9 Million
88,091 New
88,091 $31.9 Million
Q1 2020

Apr 21, 2020

SELL
$255.3 - $340.05 $21.7 Million - $28.9 Million
-84,878 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$271.93 - $328.04 $2.06 Million - $2.49 Million
7,593 Added 9.82%
84,878 $27.6 Million
Q3 2019

Nov 07, 2019

BUY
$268.46 - $305.43 $1.82 Million - $2.07 Million
6,791 Added 9.63%
77,285 $22.5 Million
Q2 2019

Aug 06, 2019

SELL
$257.51 - $295.55 $342,230 - $392,785
-1,329 Reduced 1.85%
70,494 $20.7 Million
Q1 2019

May 06, 2019

BUY
$212.17 - $273.72 $1.11 Million - $1.43 Million
5,230 Added 7.85%
71,823 $19.7 Million
Q4 2018

Feb 11, 2019

BUY
$208.47 - $251.98 $1.24 Million - $1.49 Million
5,932 Added 9.78%
66,593 $14.9 Million
Q3 2018

Nov 14, 2018

BUY
$205.57 - $244.32 $1.58 Million - $1.88 Million
7,687 Added 14.51%
60,661 $14.8 Million
Q2 2018

Jul 30, 2018

BUY
$203.14 - $219.53 $10.8 Million - $11.6 Million
52,974 New
52,974 $11 Million
Q1 2018

Apr 16, 2018

SELL
$192.98 - $224.11 $7.87 Million - $9.14 Million
-40,784 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$182.03 - $200.37 $462,720 - $509,340
2,542 Added 6.65%
40,784 $7.75 Million
Q3 2017

Oct 26, 2017

BUY
$171.74 - $194.04 $800,480 - $904,420
4,661 Added 13.88%
38,242 $7.24 Million
Q2 2017

Aug 15, 2017

BUY
N/A
33,581
33,581 $5.86 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.